Rhythm Pharmaceuticals Inc (RYTM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Rhythm Pharmaceuticals Inc   (NASDAQ: RYTM)
 

Rhythm Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Rhythm Pharmaceuticals Inc inventory turnover ratio, the Rhythm Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.99 in the second quarter 2026, yet the ratio remained below the average, as RYTM's market remain challenging.Average inventory processing period, for the Rhythm Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 369 days, compare to 380 days, in the Mar 31 2026 quarter.

Within Healthcare sector 314 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 660 in the first quarter 2026, to 1817.

RYTM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rhythm Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RYTM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 61.71 % 48.33 % 37.42 % 59.1 % 57.35 %
Y / Y Cost of Sales Growth 61.12 % 96.19 % 26.84 % 43.65 % 88.09 %
Inventory Turnover Ratio (TTM) 0.99 0.96 0.91 0.94 0.95
RYTM's Total Ranking # 1817 # 660 # 1381 # 1155 # 1454
Average inventory processing period 370 378 403 390 385
Seq. Inventory Growth 6.51 % 11.25 % 16.49 % 17.14 % -2.3 %
Seq. Cost of Sales Growth 24.79 % 49.04 % -12.68 % -0.79 % 51.95 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 93
Healthcare Sector # 315
Overall Market # 1817

Inventory Turnover Ratio Statistics
High Average Low
1.38 1.09 0.89
(Mar 31 2024)   (Mar 31 2025)



RYTM Company Profile >> Back to RYTM Efficiency Comparisons >> Compare RYTM Inventory Turnover Ratio to its Competitors

Financial Statements
Rhythm Pharmaceuticals Inc 's Inventories $ 31 Millions Visit RYTM's Balance sheet
Rhythm Pharmaceuticals Inc 's Cost of Revenues TTM $ 26 Millions Visit RYTM's Income Statement
What are RYTM's Sales? Visit RYTM's Sales by Segment

Other Inventory Turnover Ratios
Rhythm Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RYTM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RYTM's Competitors
Inventory Turnover Ratio for RYTM's Suppliers
Inventory Turnover Ratio for RYTM's Customers

You may also want to know
RYTM's Sales Growth Rates RYTM's Pe Price to earnings ratio RYTM's Receivables Turnover Ratio RYTM's Stock Quote
RYTM's Net Income Growth Rates RYTM's Ps Price to Sales ratio RYTM's Sales per Employee RYTM's Asset Turnover Ratio
RYTM's Net Margin RYTM's Pb Price to Book ratio RYTM's Financial Strength Ratios RYTM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
China Pharma Holdings Inc  2.25 $ 3.450  Millions$ 2  Millions
Beta Bionics Inc   2.23 $ 50.111  Millions$ 22  Millions
Embecta Corp   2.19 $ 418.400  Millions$ 191  Millions
Avita Medical Inc   2.18 $ 13.950  Millions$ 6  Millions
Johnson and Johnson  2.17 $ 31,428.000  Millions$ 14,516  Millions
Anika Therapeutics Inc   2.14 $ 46.366  Millions$ 22  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Organon and Co   2.06 $ 2,899.000  Millions$ 1,405  Millions
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Immucell Corporation  1.89 $ 17.409  Millions$ 9  Millions
Safe Pro Group Inc   1.88 $ 1.089  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  1.88 $ 23.839  Millions$ 13  Millions
Sunshine Biopharma Inc   1.87 $ 24.637  Millions$ 13  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions

Date modified: 2026-08-31T16:59:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.